CPhI 2021 in Milan

As an exhibitor at this year's CPhI trade show in Milan, we were pleased to have personal contact with numerous visitors and interested parties. Intensive discussions with business partners as well as high-quality consultations on our service portfolio with potential customers underline the success of this trade fair. Already now we are looking forward to [...]

2021-11-17T11:08:47+01:0017. November 2021|

Update COVID-19!

Since the outbreak of the COVID-19 pandemic Lichtenheldt has played a key role as a system-relevant company, because the production of alcoholic disinfectants requires our special expertise in manufacturing under explosion-protected conditions. Currently, Lichtenheldt produces about half of all products under explosion-protected conditions. The capacities are currently being used to the maximum. Modern production facilities [...]

2020-09-04T16:21:10+02:004. September 2020|

Current communication on COVID-19!

Lichtenheldt reacts to the Corona-Virus In the context of the COVID-19 pandemic, Lichtenheldt, the responsible authorities assigned Lichtenheldt a considerable importance in the fight against the virus. Being a renowned pharmaceutical contract manufacturer for liquid and semi-solid forms, we are one of the system-relevant companies in Northern Germany helping to minimize the effect of the [...]

2020-04-06T10:06:12+02:006. April 2020|

Lichtenheldt is ready for Russia serialisation and aggregation

In December 2018, a Russian federal law was passed which stipulates that drugs introduced to the Russian market from July 1, 2020 must be serialised with a crypto-code. In contrast to EU serialisation, this requirement affects all drugs and not only prescription drugs. Lichtenheldt is currently adapting to the additional requirements and will provide [...]

2020-02-18T13:19:52+01:0018. February 2020|

One year of successful EU serialisation at Lichtenheldt

With Directive 2011/62/EU, the European Union launched its initiative against counterfeit medicines. Reliable serialisation and labeling systems for pharmaceutical manufacturers are intended to prevent the trade of illegal prescription drugs. As a European pharmaceutical manufacturer, Lichtenheldt has very successfully implemented the serialisation obligation for all prescription drugs (Rx products) as of February 9, 2019. All [...]

2020-02-18T12:57:48+01:0018. February 2020|
Go to Top